Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517398-26-01

Enrollment

100

Registered

2024-11-15

Start date

2022-10-18

Completion date

Unknown

Last updated

2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

Total blood loss 24 hours after the operation

Detailed description

Total blood loss on the morning af the 2nd postoperative day.

Interventions

DRUGTranexamic Acid 100 mg/ml Solution for Injection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Total blood loss 24 hours after the operation	—

Secondary

Measure	Time frame
Total blood loss on the morning af the 2nd postoperative day.	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026